Fifth Hospital of Shijiazhuang City   Report issue

Academic/Hospital Phase 4
Founded: Shijiazhuang China (1949)

Organization Overview

First Clinical Trial
2013
NCT01938820
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Fifth Hospital of Shijiazhuang City

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Liver Cirrhosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 4